Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(62.5%)

Phase 2

2(25.0%)

Phase 3

1(12.5%)

8Total

N/A(5)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06608277Phase 2Recruiting

Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSD

Role: collaborator

NCT07380789Not ApplicableRecruiting

Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine

Role: lead

NCT04697498Not ApplicableUnknown

Bilateral Bi-level Erector Spine Plane Block as a Component of General Anesthesia in Surgical Correction of Spinal Deformations

Role: lead

NCT05483647Not ApplicableCompleted

ERECTOR SPINE PLANE BLOCK VERSUS LOCAL INFILTRATION ANAESTHESIA FOR TRANSFORAMINAL PERCUTANEOUS ENDOSCOPIC DISCECTOMY

Role: lead

NCT03860428Not ApplicableCompleted

Early Treatment Versus Expectant Management of PDA in Preterm Infants

Role: lead

NCT04498923Completed

Duration of Blockade of Peripheral Nerves With Bupivacaine Depending of the Adjuvants

Role: lead

NCT04500067Phase 3Completed

Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment

Role: collaborator

NCT03848273Unknown

Post Stroke Epileptic Seizures Risk Forecast

Role: lead

NCT02839239Not ApplicableCompleted

Lactocare Baby Drops in Infants Colic

Role: collaborator

NCT01510938Phase 2Completed

Probiotics in Respiratory Tract Infections in Children

Role: lead

All 10 trials loaded